Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical TrialGilda Lemos, Gerardo Guillén, Yisel Ávila-Albuerne et al.|Vaccines|2024Cited by 5
Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical TrialGilda Lemos, Gerardo Guillén, Yinet Barrese-Pérez et al.|Preprints.org|2024Cited by 2